Artwork

Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D.

14:52
 
Share
 

Manage episode 415411681 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the condition, which severely impacts multiple organs and blood.

(00:31)
Could you please provide a little bit about yourself and your background?

(01:30)
Would you please share a brief overview of the UBA1Q assay?

(02:13)
Would you provide an overview of VEXAS syndrome?

(05:30)
When is this testing recommended during care for patients who have a suspected inflammatory condition or VEXAS syndrome?

(06:38)
What advantage does this assay provide over other methodologies?

(10:13)
Could you share further why diagnosis is so important for these patients?

(12:40)
Is there anything else you'd like to comment about the assay?

  continue reading

308 episodes

Artwork
iconShare
 
Manage episode 415411681 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the condition, which severely impacts multiple organs and blood.

(00:31)
Could you please provide a little bit about yourself and your background?

(01:30)
Would you please share a brief overview of the UBA1Q assay?

(02:13)
Would you provide an overview of VEXAS syndrome?

(05:30)
When is this testing recommended during care for patients who have a suspected inflammatory condition or VEXAS syndrome?

(06:38)
What advantage does this assay provide over other methodologies?

(10:13)
Could you share further why diagnosis is so important for these patients?

(12:40)
Is there anything else you'd like to comment about the assay?

  continue reading

308 episodes

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide